Wockhardt Limited (BOM:532300)
2,183.10
-3.50 (-0.16%)
At close: Nov 20, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 354.95 billion as of November 20, 2026. Its market cap has increased by 64.17% in one year.
Market Cap
354.95B
Enterprise Value
373.62B
Revenue
38.40B
Global Rank
n/a
Country Rank
n/a
PE Ratio
85.46
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 354.95B, an increase of 1,939.49%. That is a compound annual growth rate of 12.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 354.95B | 51.04% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 619.94B |
| Gland Pharma | 549.34B |
| Ipca Laboratories | 466.56B |
| Emcure Pharmaceuticals | 443.66B |
| Ajanta Pharma | 414.52B |
| Wockhardt | 353.36B |
| Piramal Pharma | 317.20B |
| Alembic Pharmaceuticals | 205.40B |